Athos KG

Family Office Bavaria, Germany ·Founded 2005

Overview

Athos KG is a family office established by German entrepreneurs Thomas and Andreas Strüngmann, renowned for their significant contributions to the healthcare and biotechnology sectors. The Strüngmann brothers co-founded Hexal AG, a leading generic drug manufacturer, which was sold to Novartis in 2005 for $6.7 billion. Building upon this success, they established their family office to manage their wealth and continue their investment endeavors in the life sciences industry. The family office employs a diversified investment strategy, allocating capital across private and public markets, real assets, and direct investments. Their focus spans various stages of company development, including early-stage ventures, growth-stage companies, late-stage investments, pre-IPO opportunities, and buyouts. This approach enables them to support a wide range of companies within the healthcare and biotechnology sectors, from innovative startups to established industry leaders. Athos KG's investment philosophy is centered on long-term value creation, emphasizing sustainable growth and the advancement of groundbreaking technologies in the life sciences. Their portfolio includes a variety of companies involved in pharmaceuticals, biotechnology, medical devices, diagnostics, and digital health, reflecting their commitment to enhancing healthcare outcomes and driving innovation in the sector.

Investment Focus

  • Strong management teams
  • Innovative technologies
  • Scalable business models
  • Potential for significant impact in the healthcare sector
  • Alignment with long-term value creation objectives

Portfolio Companies

BioNTechKonuxAraris BiotechImmaticsInboltAMSilkStarfaceNosoexEfficient EnergyMLaseDCONSecurepointAraComslashwhy

Get the full list of 54,000+ investors

Athos KG and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription
  • All 54,000+ investors — VC firms, private equity, family offices and angels
  • The key person to contact at each one, with their job title
  • Their work email address
  • Their phone number
  • Their LinkedIn profile
  • Delivered as a single .xlsx file — download it as many times as you like
Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Athos KG

What sectors does Athos KG invest in?

Athos KG invests in Healthcare, Healthcare Services, Digital Health, Pharmaceuticals, Medical Devices and Diagnostics, and is based in Bavaria, Germany. Athos KG is listed as a family office in the ConnectSafely investor database.

What stage does Athos KG invest at?

Athos KG backs companies at Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 1M - 50M.

Which regions does Athos KG invest in?

Athos KG invests across United States, United Kingdom, Germany, France, Italy and Denmark.

What companies has Athos KG invested in?

Athos KG's portfolio includes BioNTech, Konux, Araris Biotech, Immatics, Inbolt, AMSilk, Starface and Nosoex.

Last updated · Source: ConnectSafely investor database